XXV EFMC International Symposium on Medicinal Chemistry
Ljubljana, Slovenia September 2-6, 2018
University of Ljubljana, Ljubljana, Slovenia
Novartis Institutes for Biomedical Research, Basel, Switzerland
Sapienza University of Rome, Rome, Italy
BioAscent, Glasgow, United Kingdom
Boehringer Ingelheim, Biberach an der Riss, Germany
Novo Nordisk, Cambridge, United States
Idorsia Pharmaceuticals, Allschwil, Switzerland
National Institute of Chemistry, Ljubljana, Slovenia
University of Ljubljana, Ljubljana, Slovenia
University of Ljubljana, Ljubljana, Slovenia
University of Ljubljana, Ljubljana, Slovenia
Lek d.d., Ljubljana, Slovenia
University of Ljubljana, Ljubljana, Slovenia
Acies Bio, Ljubljana, Slovenia
F. Hoffmann-La Roche, Ljubljana, Slovenia
University of Ljubljana, Ljubljana, Slovenia
University of Ljubljana, Ljubljana, Slovenia
Institute of Physiologically Active Compounds, Черноголовка, Russia
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Merck, Sharp & Dohme, Boston, United States
F. Hoffmann-La Roche, Basel, Switzerland
Vertex Pharmaceuticals, Boston, United States
Johnson & Johnson R&D, San Diego, United States
University of Cape Town, Cape Town, South Africa
BenevolentAI, Cambridge, United Kingdom
University of Parma, Parma, Italy
University of Sao Paulo, Ribeirao Preto, Brazil
Institut Pasteur of Lille, Lille, France
Nerviano Medical Sciences, Nerviano, Italy
Wroclav University of Technology, Wroclaw, Poland
King's College London, London, United Kingdom
University of Ljubljana, Ljubljana, Slovenia
Instituto de Quimica Medic, CSIC, Madrid, Spain
University of New South Wales, UNSW Sydney, Australia
UCB Pharma S.A., Braine-l'Alleud, Belgium
Novartis Pharma AG, Basel, Switzerland
Merck Biopharma, Darmstadt, Germany
Leiden University, Leiden, The Netherlands
Bayer, Wuppertal, Germany
Cancer Research UK Manchester Institute, Manchester, United Kingdom
Latvian Institute of Organic Synthesis, Riga, Latvia
Hungarian Academy of Sciences, Budapest, Hungary
University of Tübingen, Tübingen, Germany
AstraZeneca, Gothenburg, Sweden
Sanofi, Natick, United States
Instituto Superior Técnico, ULisboa, Lisboa, Portugal
Janssen R&D, Belgium
Aptuit, Verona, Italy
Inventiva, Daix, France
ETH Zürich, Zürich, Switzerland
Lund University/Galecto Biotech, Lund, Sweden
Polyphor, Allschwil, Switzerland
Boehringer Ingelheim, Biberach, Germany
Orion Pharma, Espoo, Finland
TES Pharma srl, Corciano, Italy
Rudjer Boskovic Institute, Zagreb, Croatia
Grünenthal, Germany
Astex Pharmaceuticals, Cambridge, United Kingdom
Edelris, Lyon, France
University of Geneva, Genève, Switzerland
University of Belgrade, Belgrade, Serbia
VUB, Brussels, Belgium
IRBM - MRL, Naples, Italy
Research Center for Molecular Medicine (CEMM), Vienna, Austria
Imperial College London, London, United Kingdom
Pfizer, New-York, United States
VU University Amsterdam, Oegstgeest, The Netherlands
University of Manchester, Manchester, United Kingdom
Merck KGaA, Billerican, MA, United States
MercachemSyncom, Nijmegen, The Netherlands
BAYER AG, Berlin, Germany
Max Planck Institute of Molecular Physiology, Dortmund, Germany
Amgen, Shanghai City, China
EKPA - ELKE, Athens, Greece